Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Recent filings | ||||||
Filed 2024-10-03 15:28 Tx date 2024-09-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$25,000
+49,020 vol $0.51 each |
1,475,525 | |
Older filings | ||||||
Filed 2024-09-20 11:38 Tx date 2024-09-19 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,215
+18,500 vol $0.39 each |
1,175,260 | |
Filed 2024-09-20 11:38 Tx date 2024-09-19 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,657
+9,500 vol $0.385 each |
1,156,760 | |
Filed 2024-09-20 11:37 Tx date 2024-09-19 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,900
+5,000 vol $0.38 each |
1,147,260 | |
Filed 2024-09-20 11:37 Tx date 2024-09-19 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,590
+7,000 vol $0.37 each |
1,142,260 | |
Filed 2024-09-20 11:36 Tx date 2024-09-17 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$3,810
+10,000 vol $0.381 each |
1,135,260 | |
Filed 2024-09-18 08:34 Tx date 2024-09-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,641
+296 vol $15.68 each |
366,528 | |
Filed 2024-09-13 15:33 Tx date 2024-09-12 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+5,000 vol $0.32 each |
1,125,260 | |
Filed 2024-09-13 15:32 Tx date 2024-09-11 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,260
+4,000 vol $0.315 each |
1,120,260 | |
Filed 2024-09-13 15:32 Tx date 2024-09-10 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,575
+5,000 vol $0.315 each |
1,116,260 | |
Filed 2024-09-13 15:31 Tx date 2024-09-09 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,705
+5,500 vol $0.31 each |
1,111,260 | |
Filed 2024-09-11 19:26 Tx date 2024-09-06 |
$FLGC
Flora Growth Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$4,850
+5,000 vol $0.97 each |
25,000 | |
Filed 2024-09-09 19:14 Tx date 2024-09-06 |
$FLGC
Flora Growth Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$19,400
+20,000 vol $0.97 each |
20,000 | |
Filed 2024-09-09 19:11 Tx date 2024-08-29 |
$FLGC
Flora Growth Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-08-16 10:44 Tx date 2024-08-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,648
+332 vol $14.00 each |
366,232 | |
Filed 2024-07-16 14:33 Tx date 2024-07-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,650
+557 vol $8.35 each |
365,900 | |
Filed 2024-07-04 09:30 Tx date 2024-06-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$16,667
+64,104 vol $0.26 each |
1,426,505 | |
Filed 2024-07-03 16:54 Tx date 2024-06-30 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights DSU
56 - Grant of rights
|
+14,440 vol |
131,300 | |
Filed 2024-06-17 09:37 Tx date 2024-06-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,655
+537 vol $8.67 each |
365,343 | |
Filed 2024-06-07 18:26 Tx date 2024-06-07 |
$NVRO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Holder: Princeville Capital Corporation (Indirect Ownership)
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$40,000
+500,000 vol $0.08 each |
500,000 | |
Filed 2024-06-07 18:24 Tx date 2021-07-14 |
$NVRO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Holder: Princeville Capital Corporation (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-06-07 18:24 Tx date 2024-06-07 |
$NVRO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Holder: Princeville Capital Corporation (Indirect Ownership)
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$25,000
+500,000 vol $0.05 each |
500,000 | |
Filed 2024-06-07 18:24 Tx date 2021-07-14 |
$NVRO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Holder: Princeville Capital Corporation (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2024-06-03 17:55 Tx date 2024-05-29 |
$UIG
Urban Infrastructure Group Inc. |
Wolkin, Harold Morton
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
50 - Grant of options
|
$93,000
+516,667 vol $0.18 each |
1,521,668 | |
Filed 2024-05-16 15:39 Tx date 2024-05-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,656
+518 vol $8.99 each |
364,806 | |
Filed 2024-05-04 07:12 Tx date 2024-04-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,333
+32,050 vol $0.26 each |
1,362,401 | |
Filed 2024-04-19 08:21 Tx date 2024-04-18 |
$CIII
Cytophage Technologies Ltd. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,600
+4,000 vol $0.40 each |
599,400 | |
Filed 2024-04-15 16:52 Tx date 2024-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,658
+527 vol $8.84 each |
364,288 | |
Filed 2024-04-12 21:59 Tx date 2024-04-12 |
$CIII
Cytophage Technologies Ltd. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$2,760
+6,000 vol $0.46 each |
595,400 | |
Filed 2024-04-03 14:18 Tx date 2024-03-31 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights DSU
56 - Grant of rights
|
+14,654 vol |
116,860 | |
Filed 2024-04-03 14:18 Tx date 2024-03-31 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights DSU
56 - Grant of rights
|
+14,654 vol |
116,860 | |
Filed 2024-04-02 16:47 Tx date 2024-03-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$110,862
+443,450 vol $0.25 each |
1,330,351 | |
Filed 2024-04-02 16:46 Tx date 2024-03-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,334
+33,336 vol $0.25 each |
886,901 | |
Filed 2024-03-19 09:53 Tx date 2024-03-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,660
+606 vol $7.69 each |
363,761 | |
Filed 2024-03-15 11:05 Tx date 2024-03-14 |
$CIII
Cytophage Technologies Ltd. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,882
+3,900 vol $0.4826 each |
589,400 | |
Filed 2024-03-08 20:19 Tx date 2024-03-07 |
$CIII
Cytophage Technologies Ltd. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,494
+3,000 vol $0.4983 each |
585,500 | |
Filed 2024-03-04 13:33 Tx date 2024-02-29 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,332
+37,877 vol $0.22 each |
853,565 | |
Filed 2024-02-20 09:58 Tx date 2024-02-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,655
+667 vol $6.98 each |
363,155 | |
Filed 2024-02-02 10:52 Tx date 2024-01-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,333
+29,761 vol $0.28 each |
815,688 | |
Filed 2024-01-18 12:21 Tx date 2024-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,658
+795 vol $5.86 each |
362,488 | |
Filed 2024-01-04 10:00 Tx date 2023-12-31 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights DSU
56 - Grant of rights
|
+18,793 vol |
102,206 | |
Filed 2024-01-02 14:55 Tx date 2023-12-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,334
+49,024 vol $0.17 each |
785,927 | |
Filed 2023-12-26 12:59 Tx date 2023-12-22 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$99,907
+525,830 vol $0.19 each |
1,105,760 | |
Filed 2023-12-26 12:57 Tx date 2023-12-22 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights (Rights Offering)
57 - Exercise of rights
|
$-99,907.70
-525,830 vol $0.19 each |
0 | |
Filed 2023-12-26 12:56 Tx date 2023-12-22 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights (Rights Offering)
56 - Grant of rights
|
+525,830 vol |
525,830 | |
Filed 2023-12-26 12:54 Tx date 2013-11-27 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights (Rights Offering)
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-12-20 12:55 Tx date 2023-12-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,591
+713 vol $6.44 each |
361,693 | |
Filed 2023-12-04 17:06 Tx date 2023-11-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,332
+46,294 vol $0.18 each |
736,903 | |
Filed 2023-11-27 16:55 Tx date 2023-11-23 |
$NVRO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Unit
50 - Grant of options
|
+222,103 vol |
553,753 | |
Filed 2023-11-17 14:15 Tx date 2023-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,626
+883 vol $5.24 each |
360,980 | |
Filed 2023-11-03 08:23 Tx date 2023-10-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,333
+33,332 vol $0.25 each |
690,609 | |
Filed 2023-10-24 14:01 Tx date 2023-10-23 |
$BYND
BYND Cannasoft Enterprises Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+12,145 vol |
34,455 | |
Filed 2023-10-24 14:01 Tx date 2023-07-04 |
$BYND
BYND Cannasoft Enterprises Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+7,853 vol |
22,310 | |
Filed 2023-10-24 14:00 Tx date 2023-04-04 |
$BYND
BYND Cannasoft Enterprises Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+4,819 vol |
14,457 | |
Filed 2023-10-24 14:00 Tx date 2023-01-01 |
$BYND
BYND Cannasoft Enterprises Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+4,819 vol |
9,638 | |
Filed 2023-10-24 13:51 Tx date 2023-08-08 |
$BYND
BYND Cannasoft Enterprises Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$96,500
+50,000 vol $1.93 each |
290,000 | |
Filed 2023-10-04 14:34 Tx date 2023-09-30 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights DSU
56 - Grant of rights
|
+19,626 vol |
83,413 | |
Filed 2023-10-03 07:29 Tx date 2023-09-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,334
+26,044 vol $0.32 each |
657,277 | |
Filed 2023-09-22 16:10 Tx date 2023-09-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,617
+1,026 vol $4.50 each |
359,015 | |
Filed 2023-09-04 16:20 Tx date 2023-08-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,333
+29,761 vol $0.28 each |
631,233 | |
Filed 2023-08-17 12:54 Tx date 2023-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,615
+1,330 vol $3.47 each |
357,989 | |
Filed 2023-08-03 15:42 Tx date 2023-07-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,332
+20,324 vol $0.41 each |
601,472 | |
Filed 2023-07-18 13:30 Tx date 2023-07-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,635
+1,332 vol $3.48 each |
356,659 | |
Filed 2023-07-05 10:04 Tx date 2023-06-30 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights DSU
56 - Grant of rights
|
+12,837 vol |
63,787 | |
Filed 2023-07-05 08:44 Tx date 2023-06-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,334
+23,150 vol $0.36 each |
581,148 | |
Filed 2023-06-26 16:59 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
12,876 | |
Filed 2023-06-26 16:59 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
12,876 | |
Filed 2023-06-26 16:57 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,450
+5,000 vol $3.69 each |
42,521 | |
Filed 2023-06-26 16:57 Tx date 2023-06-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$18,450
+5,000 vol $3.69 each |
42,521 | |
Filed 2023-06-16 09:59 Tx date 2023-06-14 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,586
+1,207 vol $3.80 each |
355,327 | |
Filed 2023-06-02 11:07 Tx date 2023-05-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,332
+23,147 vol $0.36 each |
557,998 | |
Filed 2023-05-15 13:17 Tx date 2023-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,263
+1,562 vol $3.37 each |
354,120 | |
Filed 2023-05-02 15:47 Tx date 2023-04-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,333
+18,939 vol $0.44 each |
534,851 | |
Filed 2023-04-22 21:37 Tx date 2023-04-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,012
+1,180 vol $3.40 each |
352,558 | |
Filed 2023-04-09 19:28 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-7,500 vol |
5,376 | |
Filed 2023-04-09 19:12 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
-7,500 vol |
||
Filed 2023-04-09 19:08 Tx date 2023-03-29 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$28,125
+7,500 vol $3.75 each |
351,378 | |
Filed 2023-04-09 19:02 Tx date 2021-03-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
14,376 | |
Filed 2023-04-05 10:12 Tx date 2023-03-31 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights DSU
56 - Grant of rights
|
+11,935 vol |
50,950 | |
Filed 2023-04-04 14:29 Tx date 2023-04-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,333
+18,117 vol $0.46 each |
515,912 | |
Filed 2023-03-21 14:49 Tx date 2023-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,620
+1,216 vol $3.80 each |
343,878 | |
Filed 2023-03-03 11:29 Tx date 2023-03-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,333
+21,367 vol $0.39 each |
497,795 | |
Filed 2023-03-01 00:50 Tx date 2023-02-27 |
$NVRO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Unit
50 - Grant of options
|
+331,650 vol |
331,650 | |
Filed 2023-03-01 00:49 Tx date 2021-07-14 |
$NVRO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-02-21 13:56 Tx date 2023-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,617
+1,279 vol $3.61 each |
342,662 | |
Filed 2023-02-09 22:37 Tx date 2023-02-06 |
$NVRO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Convertible Notes
16 - Acquisition or disposition under a prospectus exemption
|
+$50,000 vol |
$50,000 | |
Filed 2023-02-09 22:37 Tx date 2021-07-14 |
$NVRO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Convertible Notes
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2023-02-08 10:45 Tx date 2023-02-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,332
+17,006 vol $0.49 each |
476,428 | |
Filed 2023-01-18 15:38 Tx date 2023-01-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,636
+1,243 vol $3.73 each |
341,383 | |
Filed 2023-01-05 11:00 Tx date 2022-12-31 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights DSU
56 - Grant of rights
|
+13,863 vol |
39,015 | |
Filed 2023-01-04 16:26 Tx date 2023-01-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,333
+22,524 vol $0.37 each |
459,422 | |
Filed 2022-12-20 10:32 Tx date 2022-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,309
+1,105 vol $3.90 each |
340,140 | |
Filed 2022-12-05 11:04 Tx date 2022-12-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,332
+28,734 vol $0.29 each |
436,898 | |
Filed 2022-11-17 10:56 Tx date 2022-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,318
+1,259 vol $3.43 each |
339,035 | |
Filed 2022-11-03 15:58 Tx date 2022-11-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,332
+37,877 vol $0.22 each |
408,164 | |
Filed 2022-10-26 12:15 Tx date 2022-10-24 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,277
+1,407 vol $3.04 each |
337,776 | |
Filed 2022-10-11 13:52 Tx date 2022-10-03 |
$BYND
BYND Cannasoft Enterprises Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
36 - Conversion or exchange
|
+9,638 vol |
9,638 | |
Filed 2022-10-11 13:49 Tx date 2022-10-03 |
$BYND
BYND Cannasoft Enterprises Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
70 - Acquisition or disposition (writing) of third party derivative
|
-140,000 vol |
0 | |
Filed 2022-10-11 13:45 Tx date 2022-10-03 |
$BYND
BYND Cannasoft Enterprises Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$114,800
+140,000 vol $0.82 each |
140,000 | |
Filed 2022-10-11 13:40 Tx date 2021-03-30 |
$BYND
BYND Cannasoft Enterprises Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-10-05 10:58 Tx date 2022-10-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,334
+27,780 vol $0.30 each |
370,287 | |
Filed 2022-10-04 15:59 Tx date 2022-09-30 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights DSU
56 - Grant of rights
|
+10,444 vol |
25,152 | |
Filed 2022-09-19 11:44 Tx date 2022-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,569
+1,523 vol $3.00 each |
336,369 | |
Filed 2022-09-06 12:15 Tx date 2022-09-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,333
+22,522 vol $0.37 each |
342,507 | |
Filed 2022-08-22 11:20 Tx date 2022-08-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,584
+2,002 vol $2.29 each |
334,846 | |
Filed 2022-08-04 09:48 Tx date 2022-08-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,332
+18,115 vol $0.46 each |
319,985 | |
Filed 2022-07-18 12:53 Tx date 2022-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,020
+1,836 vol $2.19 each |
332,844 | |
Filed 2022-07-17 21:38 Tx date 2022-07-04 |
$BYND
BYND Cannasoft Enterprises Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
46 - Compensation for services
|
+4,819 vol |
4,819 | |
Filed 2022-07-17 21:35 Tx date 2021-03-30 |
$BYND
BYND Cannasoft Enterprises Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-07-07 11:29 Tx date 2022-06-30 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights DSU
56 - Grant of rights
|
+9,254 vol |
14,708 | |
Filed 2022-07-04 14:12 Tx date 2022-07-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,334
+17,732 vol $0.47 each |
301,870 | |
Filed 2022-06-23 15:52 Tx date 2022-06-22 |
$NVRO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$94,008
+354,750 vol $0.265 each |
1,370,821 | |
Filed 2022-06-21 09:51 Tx date 2022-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,032
+1,716 vol $2.35 each |
331,008 | |
Filed 2022-06-03 11:39 Tx date 2022-06-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,333
+14,124 vol $0.59 each |
284,138 | |
Filed 2022-05-26 11:27 Tx date 2022-05-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,414
+1,716 vol $1.99 each |
329,292 | |
Filed 2022-04-26 14:16 Tx date 2022-04-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,415
+1,634 vol $2.09 each |
327,576 | |
Filed 2022-04-08 18:55 Tx date 2022-04-06 |
$NVRO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$42,000
+87,500 vol $0.48 each |
87,500 | |
Filed 2022-04-08 18:54 Tx date 2021-07-14 |
$NVRO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-04-05 10:08 Tx date 2022-03-31 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights DSU
56 - Grant of rights
|
+5,454 vol |
5,454 | |
Filed 2022-04-05 10:06 Tx date 2022-01-01 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights DSU
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2022-04-04 19:15 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-7,500 vol |
5,376 | |
Filed 2022-04-04 19:14 Tx date 2022-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$15,674
+7,500 vol $2.09 each |
325,942 | |
Filed 2022-04-03 17:05 Tx date 2022-04-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,333
+9,804 vol $0.85 each |
258,902 | |
Filed 2022-03-30 14:25 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+7,500 vol |
12,876 | |
Filed 2022-03-30 14:24 Tx date 2022-03-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$10,850
+5,000 vol $2.17 each |
37,521 | |
Filed 2022-03-21 13:34 Tx date 2022-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,415
+2,070 vol $1.65 each |
318,442 | |
Filed 2022-03-02 21:36 Tx date 2022-01-25 |
$NVRO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$71,750
+175,000 vol $0.41 each |
778,750 | |
Filed 2022-03-02 20:26 Tx date 2022-03-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,333
+9,363 vol $0.89 each |
249,098 | |
Filed 2022-02-20 12:54 Tx date 2022-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,415
+1,908 vol $1.79 each |
316,372 | |
Filed 2022-02-02 16:14 Tx date 2022-02-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$8,332
+9,157 vol $0.91 each |
239,735 | |
Filed 2022-01-20 17:00 Tx date 2022-01-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$9,115
+5,121 vol $1.78 each |
314,464 | |
Filed 2022-01-05 12:57 Tx date 2022-01-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,657
+7,741 vol $0.86 each |
230,578 | |
Filed 2022-01-04 20:44 Tx date 2022-01-01 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
2,300 | ||
Filed 2021-12-06 09:28 Tx date 2021-12-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,681
+8,791 vol $0.76 each |
222,837 | |
Filed 2021-11-18 10:01 Tx date 2021-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,563
+1,967 vol $2.32 each |
309,343 | |
Filed 2021-11-04 17:19 Tx date 2021-11-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,669
+8,442 vol $0.79 each |
214,046 | |
Filed 2021-10-28 20:19 Tx date 2021-10-25 |
$DPCCP
Deal Pro Capital Corporation |
Wolkin, Harold Morton
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$500.00
+5,000 vol $0.10 each |
1,005,001 | |
Filed 2021-10-25 10:42 Tx date 2021-10-21 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$161,500
+190,000 vol $0.85 each |
579,930 | |
Filed 2021-10-20 11:54 Tx date 2021-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,551
+1,828 vol $2.49 each |
307,376 | |
Filed 2021-10-04 08:59 Tx date 2021-10-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,649
+7,643 vol $0.87 each |
205,604 | |
Filed 2021-09-20 16:46 Tx date 2021-09-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,552
+1,881 vol $2.42 each |
305,548 | |
Filed 2021-09-03 13:33 Tx date 2021-08-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,125
-9,500 vol $0.75 each |
389,930 | |
Filed 2021-09-03 13:32 Tx date 2021-08-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-2,960
-4,000 vol $0.74 each |
399,430 | |
Filed 2021-09-03 13:30 Tx date 2021-08-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-5,390
-7,000 vol $0.77 each |
403,430 | |
Filed 2021-09-03 13:30 Tx date 2021-08-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-7,220
-9,500 vol $0.76 each |
410,430 | |
Filed 2021-09-02 17:38 Tx date 2021-09-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,683
+8,911 vol $0.75 each |
197,961 | |
Filed 2021-08-31 17:21 Tx date 2021-08-26 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$21,450
+30,000 vol $0.71 each |
419,930 | |
Filed 2021-08-20 11:15 Tx date 2021-08-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,570
+2,320 vol $1.97 each |
303,667 | |
Filed 2021-08-05 08:06 Tx date 2021-08-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,633
+6,983 vol $0.95 each |
189,050 | |
Filed 2021-07-27 12:43 Tx date 2021-07-20 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,548
+2,808 vol $1.62 each |
301,347 | |
Filed 2021-07-14 17:31 Tx date 2021-07-14 |
$RGO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
603,750 | ||
Filed 2021-07-14 15:24 Tx date 2021-07-14 |
$RGO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
1,016,071 | ||
Filed 2021-07-14 15:22 Tx date 2021-07-14 |
$RGO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2021-07-14 15:22 Tx date 2021-07-14 |
$RGO
Envirogold Global Limited |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,016,071 | ||
Filed 2021-07-06 10:34 Tx date 2021-07-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,692
+5,769 vol $1.16 each |
182,067 | |
Filed 2021-06-22 12:38 Tx date 2021-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,875
+2,768 vol $1.40 each |
298,539 | |
Filed 2021-06-04 10:39 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
5,376 | |
Filed 2021-06-02 21:14 Tx date 2021-06-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,346
+3,157 vol $1.06 each |
176,298 | |
Filed 2021-05-28 14:40 Tx date 2021-05-28 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,578
+3,202 vol $1.43 each |
295,771 | |
Filed 2021-05-26 10:21 Tx date 2021-03-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$1,575
+1,500 vol $1.05 each |
289,199 | |
Filed 2021-05-04 15:22 Tx date 2021-05-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,322
+2,616 vol $1.27 each |
173,141 | |
Filed 2021-04-23 10:25 Tx date 2021-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,549
+3,370 vol $1.35 each |
291,069 | |
Filed 2021-04-02 12:37 Tx date 2021-03-30 |
$
BYND Cannasoft Enterprises Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
240,000 | ||
Filed 2021-04-02 12:22 Tx date 2021-04-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,323
+2,576 vol $1.29 each |
170,525 | |
Filed 2021-03-16 12:51 Tx date 2021-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,589
+5,099 vol $0.90 each |
287,699 | |
Filed 2021-03-03 13:05 Tx date 2021-03-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,329
+1,982 vol $1.68 each |
167,949 | |
Filed 2021-02-22 11:03 Tx date 2021-02-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,875
+4,726 vol $0.82 each |
282,600 | |
Filed 2021-02-05 07:23 Tx date 2021-02-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,283
+1,966 vol $1.67 each |
165,967 | |
Filed 2021-01-25 10:51 Tx date 2021-01-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,576
+4,123 vol $1.11 each |
277,874 | |
Filed 2021-01-04 15:47 Tx date 2021-01-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,319
+3,772 vol $0.88 each |
164,001 | |
Filed 2020-12-17 15:10 Tx date 2020-12-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,927
+5,455 vol $0.72 each |
273,751 | |
Filed 2020-12-05 12:32 Tx date 2020-12-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,346
+3,891 vol $0.86 each |
160,229 | |
Filed 2020-11-19 09:31 Tx date 2020-11-12 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
$4,999
+5,376 vol $0.93 each |
6,876 | |
Filed 2020-11-17 10:20 Tx date 2020-11-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,936
+4,860 vol $0.81 each |
268,296 | |
Filed 2020-11-11 22:47 Tx date 2020-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,151
+3,426 vol $0.92 each |
263,436 | |
Filed 2020-11-03 11:21 Tx date 2020-11-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,349
+3,641 vol $0.92 each |
156,338 | |
Filed 2020-10-02 11:14 Tx date 2020-10-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,326
+3,429 vol $0.97 each |
152,697 | |
Filed 2020-09-18 14:48 Tx date 2020-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,881
+3,961 vol $0.98 each |
260,010 | |
Filed 2020-09-03 17:38 Tx date 2020-09-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,316
+4,095 vol $0.81 each |
149,268 | |
Filed 2020-08-19 10:50 Tx date 2020-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,552
+6,625 vol $1.14 each |
256,049 | |
Filed 2020-08-05 08:07 Tx date 2020-08-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,333
+3,300 vol $1.01 each |
145,173 | |
Filed 2020-07-04 18:20 Tx date 2020-07-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,333
+3,115 vol $1.07 each |
141,873 | |
Filed 2020-07-04 18:19 Tx date 2020-06-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$49,997
+53,999 vol $0.93 each |
389,930 | |
Filed 2020-06-16 14:16 Tx date 2020-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,587
+3,552 vol $1.01 each |
249,424 | |
Filed 2020-06-03 15:55 Tx date 2020-06-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,333
+3,030 vol $1.10 each |
138,758 | |
Filed 2020-05-29 16:35 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+478 vol |
245,872 | |
Filed 2020-05-29 16:34 Tx date 2020-05-26 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-866 vol |
1,500 | |
Filed 2020-05-20 16:40 Tx date 2020-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,632
+3,427 vol $1.06 each |
245,394 | |
Filed 2020-05-11 16:42 Tx date 2020-05-07 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
2,366 | |
Filed 2020-05-11 16:32 Tx date 2020-05-07 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$3,150
+3,500 vol $0.90 each |
32,521 | |
Filed 2020-05-02 11:49 Tx date 2020-05-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,333
+2,755 vol $1.21 each |
135,728 | |
Filed 2020-04-21 09:22 Tx date 2020-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,646
+5,882 vol $0.62 each |
241,967 | |
Filed 2020-04-05 10:32 Tx date 2020-04-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,348
+3,849 vol $0.87 each |
132,973 | |
Filed 2020-03-18 11:46 Tx date 2020-03-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,637
+6,062 vol $0.60 each |
236,085 | |
Filed 2020-03-04 11:10 Tx date 2020-03-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,249
+3,834 vol $1.63 each |
129,124 | |
Filed 2020-02-21 15:58 Tx date 2020-02-18 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,632
+4,224 vol $0.86 each |
230,023 | |
Filed 2020-02-04 16:47 Tx date 2020-02-01 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,249
+3,378 vol $1.85 each |
125,290 | |
Filed 2020-01-20 09:44 Tx date 2020-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,615
+3,411 vol $1.06 each |
225,799 | |
Filed 2020-01-02 14:49 Tx date 2019-12-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,264
+3,332 vol $1.88 each |
121,912 | |
Filed 2019-12-16 08:19 Tx date 2019-12-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,906
+4,651 vol $0.84 each |
222,388 | |
Filed 2019-12-03 17:05 Tx date 2019-11-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,237
+3,465 vol $1.80 each |
118,580 | |
Filed 2019-11-18 16:40 Tx date 2019-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,907
+3,757 vol $1.04 each |
217,737 | |
Filed 2019-11-04 18:34 Tx date 2019-10-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,250
+2,907 vol $2.15 each |
115,115 | |
Filed 2019-10-25 17:14 Tx date 2019-10-21 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,719
+3,476 vol $1.07 each |
213,980 | |
Filed 2019-10-01 15:52 Tx date 2019-09-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,238
+2,785 vol $2.24 each |
112,208 | |
Filed 2019-09-25 10:08 Tx date 2019-09-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,629
+2,975 vol $1.22 each |
210,504 | |
Filed 2019-09-25 10:08 Tx date 2019-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,637
+3,566 vol $1.02 each |
207,529 | |
Filed 2019-08-26 15:42 Tx date 2019-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,279
+3,566 vol $1.20 each |
||
Filed 2019-09-04 09:40 Tx date 2019-08-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,257
+2,025 vol $3.09 each |
109,423 | |
Filed 2019-08-26 15:42 Tx date 2019-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$4,279
+3,566 vol $1.20 each |
207,529 | |
Filed 2019-08-02 15:38 Tx date 2019-07-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,251
+1,812 vol $3.45 each |
107,398 | |
Filed 2019-07-22 20:27 Tx date 2019-07-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,385
+3,255 vol $1.04 each |
203,963 | |
Filed 2019-07-02 18:02 Tx date 2019-06-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,257
+1,682 vol $3.72 each |
105,586 | |
Filed 2019-07-02 18:01 Tx date 2019-04-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,249
+1,528 vol $4.09 each |
102,274 | |
Filed 2019-05-01 19:12 Tx date 2019-04-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,253
+1,529 vol $4.09 each |
||
Filed 2019-06-21 13:19 Tx date 2019-06-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$7,479
+7,262 vol $1.03 each |
200,708 | |
Filed 2019-06-04 19:57 Tx date 2019-03-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,253
+1,529 vol $4.09 each |
100,746 | |
Filed 2019-06-04 19:30 Tx date 2019-05-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,242
+1,630 vol $3.83 each |
103,905 | |
Filed 2019-04-04 16:56 Tx date 2019-03-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,249
+1,528 vol $4.09 each |
||
Filed 2019-05-29 09:58 Tx date 2019-05-27 |
$DWS
Diamond Estates Wines & Spirits Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
$7,875
+46,324 vol $0.17 each |
2,580,258 | |
Filed 2019-05-01 19:12 Tx date 2019-04-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,253
+1,529 vol $4.09 each |
102,274 | |
Filed 2019-04-23 22:30 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+866 vol |
866 | |
Filed 2019-04-23 22:16 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
50 - Grant of options
|
+866 vol |
||
Filed 2019-04-23 22:14 Tx date 2019-04-11 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$2,991
+2,021 vol $1.48 each |
29,021 | |
Filed 2019-04-18 11:54 Tx date 2019-04-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,522
+3,232 vol $1.09 each |
193,446 | |
Filed 2019-04-17 13:11 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
190,214 | |
Filed 2019-04-17 13:10 Tx date 2019-04-01 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
Filed 2019-04-04 16:56 Tx date 2019-03-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,249
+1,528 vol $4.09 each |
100,745 | |
Filed 2019-03-19 Tx date 2019-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,625
+2,324 vol $1.56 each |
188,714 | |
Filed 2019-03-01 Tx date 2019-02-28 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,250
+1,532 vol $4.08 each |
99,217 | |
Filed 2019-02-19 Tx date 2019-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,632
+2,256 vol $1.61 each |
186,390 | |
Filed 2019-02-07 Tx date 2019-01-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,249
+1,488 vol $4.20 each |
97,685 | |
Filed 2019-01-17 Tx date 2019-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,611
+2,189 vol $1.65 each |
184,134 | |
Filed 2019-01-02 Tx date 2018-12-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,247
+1,750 vol $3.57 each |
96,197 | |
Filed 2018-12-20 Tx date 2018-12-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,871
+2,564 vol $1.51 each |
181,945 | |
Filed 2018-12-03 Tx date 2018-11-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,248
+1,698 vol $3.68 each |
94,447 | |
Filed 2018-11-20 Tx date 2018-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,873
+2,565 vol $1.51 each |
179,381 | |
Filed 2018-11-01 Tx date 2018-10-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,250
+1,741 vol $3.59 each |
92,749 | |
Filed 2018-10-19 Tx date 2018-10-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,886
+1,524 vol $2.55 each |
176,816 | |
Filed 2018-10-01 Tx date 2018-09-28 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,539 vol |
91,008 | |
Filed 2018-09-28 Tx date 2018-09-24 |
$DWS
Diamond Estates Wines & Spirits Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-100,000 vol |
0 | |
Filed 2018-09-28 Tx date 2018-09-24 |
$DWS
Diamond Estates Wines & Spirits Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$25,000
+100,000 vol $0.25 each |
2,533,934 | |
Filed 2018-09-19 Tx date 2018-09-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,674
+1,317 vol $2.79 each |
175,292 | |
Filed 2018-09-07 Tx date 2018-09-03 |
$DWS
Diamond Estates Wines & Spirits Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$14,124
+47,083 vol $0.30 each |
239,831 | |
Filed 2018-09-06 Tx date 2018-08-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,740 vol |
89,469 | |
Filed 2018-08-20 Tx date 2018-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,623
+1,399 vol $2.59 each |
173,975 | |
Filed 2018-08-01 Tx date 2018-07-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,251
+1,866 vol $3.35 each |
87,729 | |
Filed 2018-07-23 Tx date 2018-06-18 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,249
+1,860 vol $3.36 each |
||
Filed 2018-07-23 Tx date 2018-06-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,249
+1,860 vol $3.36 each |
85,863 | |
Filed 2018-07-19 Tx date 2018-07-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,619
+1,521 vol $2.38 each |
172,576 | |
Filed 2018-07-11 Tx date 2018-07-10 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$49,999
+16,129 vol $3.10 each |
335,931 | |
Filed 2018-07-04 Tx date 2018-06-18 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$6,249
+1,860 vol $3.36 each |
85,863 | |
Filed 2018-06-19 Tx date 2018-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,640
+1,576 vol $2.31 each |
171,055 | |
Filed 2018-06-01 Tx date 2018-05-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,922 vol |
84,003 | |
Filed 2018-05-21 Tx date 2018-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,356
+1,130 vol $2.97 each |
169,479 | |
Filed 2018-05-07 Tx date 2018-04-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,838 vol |
82,081 | |
Filed 2018-04-20 Tx date 2018-04-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,622
+1,012 vol $3.58 each |
168,349 | |
Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
1,500 | |
Filed 2018-04-06 Tx date 2018-04-03 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
167,337 | |
Filed 2018-04-02 Tx date 2018-03-29 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,630 vol |
80,243 | |
Filed 2018-03-29 Tx date 2017-07-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+3,333 vol |
||
Filed 2018-03-29 Tx date 2017-07-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,572 vol |
61,564 | |
Filed 2018-03-29 Tx date 2017-04-28 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,536 vol |
57,101 | |
Filed 2018-03-29 Tx date 2017-08-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,724 vol |
63,288 | |
Filed 2018-03-29 Tx date 2017-04-28 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+3,333 vol |
||
Filed 2018-03-29 Tx date 2017-08-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+3,333 vol |
||
Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$12,355
+3,500 vol $3.53 each |
27,000 | |
Filed 2018-03-26 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
3,000 | |
Filed 2018-03-23 Tx date 2018-03-22 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$181,500
+50,000 vol $3.63 each |
165,837 | |
Filed 2018-03-20 Tx date 2018-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,623
+1,072 vol $3.38 each |
115,837 | |
Filed 2018-03-01 Tx date 2018-02-28 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,628 vol |
83,780 | |
Filed 2018-02-20 Tx date 2018-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,621
+1,059 vol $3.42 each |
114,765 | |
Filed 2018-02-05 Tx date 2018-01-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,566 vol |
82,152 | |
Filed 2018-01-17 Tx date 2018-01-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,607
+975 vol $3.70 each |
113,706 | |
Filed 2018-01-02 Tx date 2017-12-29 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,817 vol |
80,586 | |
Filed 2017-12-19 Tx date 2017-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,864
+976 vol $3.96 each |
112,731 | |
Filed 2017-12-04 Tx date 2017-11-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+2,451 vol |
78,769 | |
Filed 2017-11-30 Tx date 2017-11-28 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$250,000
+106,383 vol $2.35 each |
319,802 | |
Filed 2017-11-17 Tx date 2017-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,875
+1,004 vol $3.86 each |
111,755 | |
Filed 2017-11-11 Tx date 2017-11-10 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$164,150
+35,000 vol $4.69 each |
110,751 | |
Filed 2017-11-03 Tx date 2017-10-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+6,183 vol |
76,318 | |
Filed 2017-10-20 Tx date 2017-10-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,698
+981 vol $3.77 each |
75,751 | |
Filed 2017-10-03 Tx date 2017-09-29 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,680 vol |
70,135 | |
Filed 2017-09-19 Tx date 2017-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,613
+899 vol $4.02 each |
74,770 | |
Filed 2017-09-05 Tx date 2017-08-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+3,333 vol |
68,455 | |
Filed 2017-09-01 Tx date 2017-08-30 |
$DWS
Diamond Estates Wines & Spirits Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
11 - Acquisition or disposition carried out privately
|
$19,118
+65,925 vol $0.29 each |
192,748 | |
Filed 2017-08-18 Tx date 2017-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,614
+791 vol $4.57 each |
73,871 | |
Filed 2017-08-01 Tx date 2017-07-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+3,333 vol |
65,122 | |
Filed 2017-07-20 Tx date 2017-07-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,610
+785 vol $4.60 each |
73,080 | |
Filed 2017-07-05 Tx date 2017-06-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,480 vol |
61,789 | |
Filed 2017-06-19 Tx date 2017-06-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,612
+767 vol $4.71 each |
72,295 | |
Filed 2017-06-01 Tx date 2017-05-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,411 vol |
60,309 | |
Filed 2017-05-30 Tx date 2017-05-30 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$83,518
+15,000 vol $5.57 each |
71,528 | |
Filed 2017-05-26 Tx date 2017-05-23 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,615
+833 vol $4.34 each |
22,328 | |
Filed 2017-05-19 Tx date 2017-05-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$17,710
+3,500 vol $5.06 each |
23,500 | |
Filed 2017-05-18 Tx date 2017-05-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$129,070
+23,700 vol $5.45 each |
55,695 | |
Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
20,518 | |
Filed 2017-05-16 Tx date 2017-05-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$56,164
+10,500 vol $5.35 each |
31,995 | |
Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
||
Filed 2017-05-16 Tx date 2017-03-31 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
Filed 2017-05-16 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
||
Filed 2017-05-02 Tx date 2017-04-28 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+3,333 vol |
58,898 | |
Filed 2017-04-20 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,614
+977 vol $3.70 each |
21,495 | |
Filed 2017-04-20 Tx date 2017-04-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,614
+977 vol $3.70 each |
||
Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
57 - Exercise of rights
|
-1,500 vol |
0 | |
Filed 2017-04-03 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+1,500 vol |
20,518 | |
Filed 2017-04-03 Tx date 2017-03-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,675 vol |
55,565 | |
Filed 2017-03-17 Tx date 2017-03-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,616
+967 vol $3.74 each |
19,018 | |
Filed 2017-03-14 Tx date 2017-01-26 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$23,920
+13,669 vol $1.75 each |
||
Filed 2017-03-14 Tx date 2017-01-26 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$23,920
+13,669 vol $1.75 each |
||
Filed 2017-03-01 Tx date 2017-02-28 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
+1,667 vol |
53,890 | |
Filed 2017-02-17 Tx date 2017-01-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,333
+1,626 vol $2.05 each |
52,223 | |
Filed 2017-02-17 Tx date 2017-02-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,610
+905 vol $3.99 each |
18,051 | |
Filed 2017-01-27 Tx date 2017-01-26 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$23,920
+13,669 vol $1.75 each |
227,088 | |
Filed 2017-01-20 Tx date 2017-01-16 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,607
+893 vol $4.04 each |
17,146 | |
Filed 2017-01-05 Tx date 2016-12-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,330
+1,699 vol $1.96 each |
50,597 | |
Filed 2016-12-23 Tx date 2016-12-22 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,085
+54,100 vol $1.85 each |
213,419 | |
Filed 2016-12-21 Tx date 2016-12-20 |
$DWS
Diamond Estates Wines & Spirits Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$90,002
+409,100 vol $0.22 each |
2,433,934 | |
Filed 2016-12-19 Tx date 2016-12-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,705
+1,074 vol $3.45 each |
16,253 | |
Filed 2016-12-17 Tx date 2016-12-16 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
15 - Acquisition or disposition under a prospectus
|
$100,085
+54,100 vol $1.85 each |
159,319 | |
Filed 2016-12-01 Tx date 2016-11-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,337
+1,652 vol $2.02 each |
48,898 | |
Filed 2016-11-17 Tx date 2016-11-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,484
+1,069 vol $3.26 each |
15,179 | |
Filed 2016-11-01 Tx date 2016-10-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,333
+1,536 vol $2.17 each |
47,246 | |
Filed 2016-10-24 Tx date 2016-10-17 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$3,340
+807 vol $4.14 each |
14,110 | |
Filed 2016-10-03 Tx date 2016-09-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,334
+1,667 vol $2.00 each |
45,710 | |
Filed 2016-09-21 Tx date 2016-09-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
$5,694
+1,303 vol $4.37 each |
13,303 | |
Filed 2016-09-01 Tx date 2016-08-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,332
+1,587 vol $2.10 each |
44,043 | |
Filed 2016-08-18 Tx date 2016-08-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-08-18 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$123,800
+20,000 vol $6.19 each |
20,000 | |
Filed 2016-08-18 Tx date 2016-08-17 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$23,237
+13,669 vol $1.70 each |
105,219 | |
Filed 2016-08-18 Tx date 2016-08-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2016-08-18 Tx date 2016-08-15 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,500 vol |
1,500 | |
Filed 2016-08-11 Tx date 2016-08-08 |
$CPH
Cipher Pharmaceuticals Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
12,000 | ||
Filed 2016-08-02 Tx date 2016-07-29 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,334
+1,667 vol $2.00 each |
42,456 | |
Filed 2016-07-30 Tx date 2016-07-27 |
$DWS
Diamond Estates Wines & Spirits Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
$6,235
+46,537 vol $0.134 each |
126,823 | |
Filed 2016-07-04 Tx date 2016-06-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,327
+1,592 vol $2.09 each |
40,789 | |
Filed 2016-06-30 Tx date 2016-06-21 |
$DWS
Diamond Estates Wines & Spirits Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
+46,296 vol |
||
Filed 2016-06-30 Tx date 2016-06-21 |
$DWS
Diamond Estates Wines & Spirits Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
99 - Correction of information
|
-46,296 vol |
80,286 | |
Filed 2016-06-23 Tx date 2016-06-21 |
$DWS
Diamond Estates Wines & Spirits Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
30 - Acquisition or disposition under a purchase/ownership plan
|
+46,296 vol |
172,878 | |
Filed 2016-06-01 Tx date 2016-05-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,327
+1,742 vol $1.91 each |
39,197 | |
Filed 2016-05-02 Tx date 2016-04-29 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,332
+1,610 vol $2.07 each |
37,455 | |
Filed 2016-04-08 Tx date 2016-04-07 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+4,368 vol |
22,326 | |
Filed 2016-04-01 Tx date 2016-03-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,332
+1,587 vol $2.10 each |
35,845 | |
Filed 2016-03-01 Tx date 2016-02-29 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,333
+1,852 vol $1.80 each |
34,258 | |
Filed 2016-02-01 Tx date 2016-01-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,333
+1,905 vol $1.75 each |
32,406 | |
Filed 2016-01-08 Tx date 2016-01-07 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+3,666 vol |
17,958 | |
Filed 2016-01-04 Tx date 2015-12-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,337
+1,766 vol $1.89 each |
30,501 | |
Filed 2015-12-28 Tx date 2015-12-23 |
$DWS
Diamond Estates Wines & Spirits Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$48,750
+650,000 vol $0.075 each |
2,024,834 | |
Filed 2015-12-24 Tx date 2015-12-24 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,070
+5,300 vol $1.90 each |
91,550 | |
Filed 2015-12-02 Tx date 2015-12-02 |
$DWS
Diamond Estates Wines & Spirits Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$7,740
+86,000 vol $0.09 each |
1,374,834 | |
Filed 2015-12-01 Tx date 2015-11-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,333
+1,634 vol $2.04 each |
28,735 | |
Filed 2015-11-24 Tx date 2015-11-23 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,764
+3,300 vol $2.05 each |
64,550 | |
Filed 2015-11-24 Tx date 2015-11-24 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$44,484
+21,700 vol $2.05 each |
86,250 | |
Filed 2015-11-20 Tx date 2013-09-23 |
$DWS
Diamond Estates Wines & Spirits Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
126,582 | ||
Filed 2015-11-02 Tx date 2015-10-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,333
+1,961 vol $1.70 each |
27,101 | |
Filed 2015-10-09 Tx date 2015-10-07 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+3,522 vol |
14,292 | |
Filed 2015-10-01 Tx date 2015-09-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,334
+1,667 vol $2.00 each |
20,140 | |
Filed 2015-10-01 Tx date 2015-09-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$40,000
+5,000 vol $8.00 each |
25,140 | |
Filed 2015-09-04 Tx date 2015-08-13 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$40,000
+5,000 vol $8.00 each |
||
Filed 2015-09-04 Tx date 2015-08-13 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$40,000
+5,000 vol $8.00 each |
||
Filed 2015-09-04 Tx date 2015-08-13 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$40,000
+5,000 vol $8.00 each |
||
Filed 2015-09-01 Tx date 2015-08-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,329
+2,148 vol $1.55 each |
23,473 | |
Filed 2015-08-18 Tx date 2015-08-13 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$40,000
+5,000 vol $8.00 each |
21,325 | |
Filed 2015-08-04 Tx date 2015-07-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,269
+2,335 vol $1.40 each |
16,325 | |
Filed 2015-07-10 Tx date 2015-04-13 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+3,738 vol |
||
Filed 2015-07-10 Tx date 2014-10-10 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+1,233 vol |
1,233 | |
Filed 2015-07-10 Tx date 2015-01-07 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+2,537 vol |
3,770 | |
Filed 2015-07-10 Tx date 2015-04-13 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+3,738 vol |
7,508 | |
Filed 2015-07-10 Tx date 2015-07-08 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Rights
56 - Grant of rights
|
+3,262 vol |
10,770 | |
Filed 2015-07-10 Tx date 2015-04-13 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+3,738 vol |
||
Filed 2015-07-10 Tx date 2014-10-10 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+1,233 vol |
||
Filed 2015-07-10 Tx date 2014-10-10 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+1,233 vol |
||
Filed 2015-07-10 Tx date 2014-10-10 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+1,233 vol |
||
Filed 2015-07-10 Tx date 2014-10-10 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+1,233 vol |
||
Filed 2015-07-10 Tx date 2015-01-07 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+2,537 vol |
||
Filed 2015-07-10 Tx date 2015-01-07 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+2,537 vol |
||
Filed 2015-07-10 Tx date 2015-01-07 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+2,537 vol |
||
Filed 2015-07-10 Tx date 2015-01-07 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+2,537 vol |
||
Filed 2015-07-10 Tx date 2015-04-13 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
30 - Acquisition or disposition under a purchase/ownership plan
|
+3,738 vol |
||
Filed 2015-07-10 Tx date 2015-04-13 |
$CRP
Ceres Global Ag Corp. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
56 - Grant of rights
|
+3,738 vol |
||
Filed 2015-07-02 Tx date 2015-06-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,325
+1,968 vol $1.69 each |
13,990 | |
Filed 2015-06-02 Tx date 2015-05-31 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,329
+1,790 vol $1.86 each |
12,022 | |
Filed 2015-05-31 Tx date 2015-05-29 |
$DWS
Diamond Estates Wines & Spirits Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
97 - Other
|
+50,834 vol |
1,288,834 | |
Filed 2015-05-01 Tx date 2015-04-30 |
$BYL
Baylin Technologies Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Deferred Share Units
56 - Grant of rights
|
$3,332
+1,307 vol $2.55 each |
10,232 | |
Filed 2015-04-30 Tx date 2015-04-29 |
$DWS
Diamond Estates Wines & Spirits Inc. |
Wolkin, Harold Morton
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$108,000
+900,000 vol $0.12 each |
1,238,000 |